Brief: Aequus Pharmaceuticals filed clinical trial application with Health Canada
15/06/2017 14:09
June 15 (Reuters) - Aequus Pharmaceuticals Inc AQS.V
* Filed clinical trial application with health canada
* Filed cta for a proof of concept clinical study for its
long-acting transdermal anti-nausea patch, aqs1303
* Approval of cta is expected in early july
Source text for Eikon: ID:nMKWrjsTCa
Further company coverage: AQS.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange